Kathleen Behrens, Director at Sarepta Therapeutics, holds 406.51K shares in IGM Biosciences (Ticker: IGMS), holds 201.09K shares in Sarepta Therapeutics (Ticker: SRPT), holds 184.16K shares in MiMedx Group (Ticker: MDXG).
What is the percentage of profitable transactions made by Kathleen Behrens?
The percentage of profitable transactions made by Kathleen Behrens is 70%.
What is the average return per transaction made by Kathleen Behrens?
The average return per transaction made by Kathleen Behrens is 54.90%.
What stocks does Kathleen Behrens hold?
Kathleen Behrens holds: SRPT, IGMS, MDXG stocks.
What was Kathleen Behrens’s latest transaction?
Kathleen Behrens latest transaction was an Uninformative Buy of ―.
What was Kathleen Behrens's most profitable transaction?
Kathleen Behrens’s most profitable transaction was an Informative Buy of IGMS stock on September 20, 2019. The return on the trade was 291.90%.
What is Kathleen Behrens's role in Sarepta Therapeutics?
Kathleen Behrens's role in Sarepta Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.